SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Stocks Crossing The 13 Week Moving Average <$10.01

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Strauss who wrote (8839)5/23/2001 1:48:59 PM
From: Jibacoa  Read Replies (3) of 13094
 
JIM:

PPHM: Is up 21.49%. It has had some good news today, as well as at the ASCO meeting last week.

TUSTIN, Calif.--(BW HealthWire)--May 23, 2001--Peregrine Pharmaceuticals Inc. (Nasdaq:PPHM - news) today announced it has granted an extension to Cancer Therapeutics Inc. to allow Brilliance Pharmaceuticals Ltd. of Shanghai, China to continue to exclusively advance the commercialization of radiolabeled TNT in China.

I also has announced a trial of Cotara on liver Cancer in combination with Radiofrequency ablation.

siliconinvestor.com

RAGL

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext